Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-018325

Chief Executive Officer sold 14,683 shares at $211.66 ($3,107,739)

  • Chief Executive Officer acquired 14,683 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2024-06-07 Option exercise 10b5-1 +14,683 $84.98 $1,247,761 455,482 D: show line 1 in the form
Farrell Michael J. Chief Executive Officer 2024-06-07 Sale 10b5-1 −14,683 $211.66 $3,107,739 440,799 D: show line 2 in the form
Open-market sales · 14,683 sh · avg $211.66 · $3,107,739

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Farrell Michael J. Chief Executive Officer 2024-06-07 Option exercise · ResMed Common Stock Options 10b5-1 −14,683 73,415 D: show line 3 in the form
Loading xslF345X05/form4.xml…